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never carried to the sites where they 
were housed or taken out for grazing. 
Thus, the only way for the infant pa-
tient to be infected would be environ-
mental exposure. Since the infant had 
not been carried to the animal sites, 
the pathogen must have been transmit-
ted to the household by the clothes or 
skin of the father or grandfather, who 
had been shepherding the infected ani-
mals. Subsequently, the baby became 
infected either by inhaling infected 
aerosolized particles or by direct 
transmission of the pathogen through 
minor skin abrasions (which were spe-
ciﬁ  cally looked for on admission but 
were not seen) or mucosal surfaces.
This case suggests that B. me-
litensis may even affect persons who 
are not directly exposed to infected 
animals, through direct contact with 
contaminated persons or the environ-
ment. In this context, brucellosis can 
be considered as not simply a house-
hold disease but as a disease of the 
house.
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Hepatitis E Virus 
Genotype 1, Cuba
To the Editor: Hepatitis E virus 
(HEV) causes acute viral hepatitis, 
which in rare cases leads to fulminant 
hepatitis with high death rates, espe-
cially among women in their third 
trimester of pregnancy (1). Sporadic 
infections and epidemics have been 
reported from all parts of the world, 
especially Asia, Africa, and Latin 
America. Although indigenous hepa-
titis E has rarely been observed in 
industrialized countries, higher than 
expected anti-HEV prevalence has 
been detected in these areas (1). In the 
Caribbean region, many countries in-
cluding Cuba, Haiti, Guatemala, and 
Honduras have reported hepatitis E 
(2,3), but the viruses have not been 
characterized.
The transmission of HEV is pri-
marily fecal–oral, through contami-
nated drinking water; limited zoonotic 
transmission has also been reported. 
Despite only 1 serotype, 4 major gen-
otypes of HEV have been reported 
(1). Genotype 1 is mainly responsible 
for sporadic infections and large out-
breaks in Asia and Africa. Genotype 
2 was ﬁ  rst found in Mexico and later 
on the African continent. Genotypes 
3 and 4 have been reported from the 
United States, Europe, China, Japan, 
and Taiwan; this group also includes 
the related swine HEV (1).
We report the phylogenetic analy-
sis of 11 HEV isolates from 2 out-
breaks and sporadic cases in Havana, 
Cuba. The ﬁ  rst outbreak occurred in 
1999 in a factory; 20 persons were af-
fected (12 women, 8 men; median age 
45 years, range 22–53 years). The sec-
ond outbreak was in 2005 in a suburb 
of Havana and involved 26 persons 
(15 women, 11 men; median age 24 
years, range 17–45 years). We also 
analyzed HEV in 12 sporadic clinical 
cases obtained from the Cuban nation-
al surveillance program for viral hepa-
titis. Most patients reported asthenia, 
epigastric pain, nausea, and vomiting. 
None had any history of international 
travel, contact with persons traveling 
from disease-endemic areas, or con-
sumption of exotic foods. Serologic 
screening showed all patients to be 
negative for immunoglobulin (Ig) M 
against hepatitis A and hepatitis C vi-
ruses. One patient had positive results 
for hepatitis B surface antigen but 
negative results for anti-hepatitis B 
core antigen IgM and hepatitis B virus 
DNA. All patients were positive for 
anti-HEV IgM (Genelab Diagnostics, 
Singapore) according to the manu-
facture’s criteria. A total of 22 serum 
samples (outbreak 1, n = 9; outbreak 
2, n = 7; sporadic cases, n = 6) were 
tested for HEV RNA; only 2 (both 
from sporadic cases) were positive. A 
total of 31 serum samples were also 
tested for anti-HEV IgG (Genelab Di-
agnostics), of which 22 were positive 
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(outbreak 1, n = 7/10; outbreak 2, n = 
10/13; sporadic cases, n = 5/8).
A total of 44 stool samples were 
collected 2–4 weeks after onset of 
symptoms and stored at –70°C until 
use. Fecal samples were screened for 
HEV open reading frame (ORF) 2 
by using reverse transcription (RT)–
PCR (4). For genotyping, nested 
RT-PCR was then performed for the 
ORF1 RdRp region (5) on 18 sam-
ples that were positive for ORF2. Of 
the 12 PCR products obtained, 11 
fragments were cloned into pGEMT 
Easy Vector (Promega, Madison, WI, 
USA). At least 3 positive clones for 
each sample were sequenced, and 
the consensus sequence was used 
for phylogenetic analysis. The Gen-
Bank accession numbers of ORF1 
for the HEV outbreak cases from 
Cuba are CUB10-1999 (EU165504), 
CUB11-1999 (EU165502), CUB13-
1999 (EU1655019), CUB19-1999 
(EU165500), CUB24-1999 (EU165
499), CUB68-2005 (EU165496), 
and CUB71-2005 (EU165495). For 
the sporadic cases they are CUB9-
2005 (EU165503), CUB1803-2003 
(EU165494), CUB2-2005 (EF493155), 
and CUB27-2005 (EU165498). Ad-
ditionally, nested RT-PCR was con-
ducted with ORF2-speciﬁ  c  primer 
pairs (6) for 2 HEV isolates, 1 each 
from outbreak and sporadic cases, and 
sequences were obtained. The acces-
sion numbers for ORF2 are outbreak 
CUB10D-1999 (EU284749) and spo-
radic CUB2D-2005 (EU284748).
Phylogenetic analysis of ORF1 
nucleotide sequences showed that 
HEV isolates from Cuba clustered in 
genotype 1 with high bootstrap values 
(Figure, panel A). The same genotype 
was detected in an outbreak of hepa-
titis E in UN peacekeepers deployed 
from Bangladesh to Haiti (3). Al-
though the outbreak was adequately 
contained, anti-HEV immunoglobu-
lin was subsequently detected in 3% 
of civilians in Haiti (3). Nucleotide 
identity between isolates from Cuba 
and other HEV strains from genotype 
1 ranged from 91.7% to 99%. The 
strains from Cuba were closely related 
to the isolates from India and shared 
97.8%–99% homology with Yam-67 
(7). Absolute ORF1 nucleotide differ-
ences (p-distances; MEGA2 software, 
www.megasoftware.net) of isolates 
from Cuba ranged from 0% to 1.6%, 
demonstrating a high degree of re-
latedness. The ORF2 analysis sup-
ported our ORF1 ﬁ  ndings because the 
CUB2D-2005 and CUB10D-1999 se-
quences also clustered with genotype 
1 (Figure, panel B). Both strains from 
Cuba shared 96.1% nucleotide ho-
mology with a prototype strain from 
Burma (Bur82) and were related to 
the strains from India (Hyderabad and 
Yam-67), sharing 97.4%–99% homol-
ogy. Absolute ORF2 nucleotide differ-
ences ranged from 0.8% to 1.9%. This 
value for ORF1 ranged from 0.05% to 
0.08% for the same isolates from Cuba 
(CUB2-2005 and CUB10-1999).
HEV shows a global presence. 
The genotype distribution, although 
dominant in a given geographic area, 
is not limited to that area. For exam-
ple, genotype 2, ﬁ  rst identiﬁ  ed on the 
American continent in Mexico (8), 
was later found in Namibia and Ni-
geria on the African continent (9,10). 
We report indigenous HEV genotype 
1 strains in the Americas.
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Figure. Phylogenetic trees constructed on the basis of A) 240 nucleotides, RdRp region, from open reading frame (ORF) 1, and B) 311 
nucleotides from ORF2. Each tree was generated by using the neighbor-joining method; the distance matrix was calculated by using the 
Kimura 2-parameter method. The robustness of the trees was determined by bootstrap for 1,000 replicates. Values >70% are shown at the 
nodes. The major branches represent hepatitis E virus genotypes. Scale bar indicates 0.05 substitutions per nucleotide position.LETTERS
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Ciproﬂ  oxacin 
Resistance in 
Neisseria 
meningitidis, 
France 
To the Editor: Infections with 
Neisseria meningitidis may occur as 
outbreaks or epidemics. Consequently, 
chemoprophylaxis for contacts is gen-
erally recommended. Ciproﬂ  oxacin is 
frequently used in adults in a conve-
nient 1-dose regimen (1). Resistance to 
this antimicrobial drug in N. meningiti-
dis is rare (MIC>0.06 mg/L) and has 
been reported only in sporadic cases 
in Greece, France, Australia, Spain, 
Argentina and Hong Kong Special 
Administrative Region, People’s Re-
public of China (2–5). However, recent 
reports have described ciproﬂ  oxacin-
resistant (Cip-R) serogroup A menin-
gococci from 2 outbreaks in Delhi, 
India, (6) and a cluster of 3 serogroup 
B meningococci in the United States 
(7). This information is of concern be-
cause of the high epidemic potential of 
serogroup A isolates, lack of vaccine 
against serogroup B meningococci, and 
possible horizontal Cip-R gene transfer 
to other meningococcal isolates.
Experimental work was conduct-
ed in the Neisseria Unit of the Institut 
Pasteur in Paris. We screened all clini-
cal N. meningitidis isolates received at 
the French National Reference Cen-
ter for Meningococci in Paris since 
1999 for ciproﬂ  oxacin resistance. Of 
these isolates, 4,900 were from France 
and 246 were from African countries 
(Burkina Faso, Cameroon, Central Af-
rican Republic, Côte d’Ivoire, Mada-
gascar, Niger, Rwanda, Senegal, and 
Tunisia). Only 3 isolates tested were 
resistant to ciproﬂ   oxacin (MICs = 
0.19 mg/L), and all were isolated from 
cases of invasive disease in France. 
Two serogroup A, serotype 4, 
serosubtype P1.9, Cip-R isolates be-
longed to different sequence types 
(STs), ST-7 (Cip-R1) and ST-4789 
(Cip-R2), although they belonged to 
the same clonal complex (ST-5/sub-
group III). Cip-R1, which showed 
decreased susceptibility to penicillin, 
was isolated in 2004 from the blood 
of a 7-year-old girl. This isolate was 
most likely imported from Africa. 
Cip-R2 was isolated from the cere-
brospinal ﬂ  uid of a 77-year-old man 
who had arrived in France from India 
in 2006. The ST of this isolate (ST-
4789) is the same as the ST of isolates 
from an outbreak in Bangladesh and 
similar to isolates from an outbreak 
in India (6; http://neisseria.org/nm/
typing/mlstdb). Cip-R3 (serogroup 
W-135, nontypeable, subtype P1.5), 
which was isolated from blood and 
cerebrospinal ﬂ  uid of an 82-year-old 
woman in 2006, belonged to a new 
ST (ST-6361). Current ciproﬂ  oxacin 
resistance has not been documented 
among invasive W-135 meningococ-
cal isolates since 2 W-135 resistant 
meningococci were isolated from 
sputum samples of elderly patients in 
Spain (3).
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